Glastonbury, CT, United States of America

Gregory M Chere

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Rtx Corporation. Active years: 2025-2026.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gregory M Chere: Innovator in Aircraft Propulsion Systems

Introduction

Gregory M Chere is a notable inventor based in Glastonbury, CT (US). He has made significant contributions to the field of aircraft propulsion systems. His innovative work focuses on enhancing the efficiency and functionality of turbine engines.

Latest Patents

Chere holds a patent for a "Fan case mounted evaporator for aircraft turbine engine." This invention involves an aircraft propulsion system that includes an exhaust duct defining a flow path for exhaust gas. The system utilizes heat from the exhaust gas to transform water from a condenser assembly into steam for injection into the core engine. The evaporator system features at least one heat exchanger stage mounted to the fan case, which communicates with the exhaust gas flow routed through the exhaust duct. This innovative design aims to improve the overall performance of aircraft engines.

Career Highlights

Gregory M Chere is currently employed at RTX Corporation, where he continues to develop cutting-edge technologies in the aerospace sector. His work at RTX Corporation has allowed him to collaborate with other talented professionals in the industry.

Collaborations

One of his notable coworkers is Jesse M Chandler, with whom he has likely shared insights and expertise in their respective fields.

Conclusion

Gregory M Chere's contributions to aircraft propulsion systems exemplify the spirit of innovation in aerospace technology. His patent reflects a commitment to improving engine efficiency and performance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…